Sucampo Pharma (SCMP) Tops Q3 EPS by 2c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Other income (expense), net: 8.1M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Other income (expense), net: 8.1M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Sucampo Pharma (NASDAQ: SCMP) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $61.3 million versus the consensus estimate of $58.05 million.
GUIDANCE:
Sucampo Pharma sees FY2017 EPS of $1.10-$1.15, versus the consensus of $1.01. Sucampo Pharma sees FY2017 revenue of $250-255 million, versus the consensus of $234.5 million.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- nVent Electric (NVT) Tops Q3 EPS by 13c ; Offers Guidance
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
